Mainz Biomed BV (MYNZ) — Tangible Net Worth Ratio
Mainz Biomed BV (MYNZ) has a Tangible Net Worth Ratio of -73.5% as of December 2025. This metric is calculated by deducting intangible assets ($1.11 Million) from net assets ($641.60K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See MYNZ total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Mainz Biomed BV Tangible Net Worth Ratio (2021–2025)
This chart shows how Mainz Biomed BV's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at -73.5%, reflecting net assets of $641.60K with intangible assets of $1.11 Million USD. Also explore Mainz Biomed BV (MYNZ) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Mainz Biomed BV (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Mainz Biomed BV from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Mainz Biomed BV market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -73.5% | $641.60K | $1.11 Million | $5.33 Million | ▼ -123.6 pp |
| 2024 | 50.1% | $6.05 Million | $3.02 Million | $13.24 Million | ▲ +54.6 pp |
| 2023 | -4.5% | $3.25 Million | $3.39 Million | $15.41 Million | ▼ -104.5 pp |
| 2022 | 100.0% | $14.10 Million | $0.00 | $20.24 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $6.36 Million | $0.00 | $10.04 Million | — |